Yakira Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Yakira Capital Management, Inc. holds 7 biotech & pharma companies tracked by BioSniper, totaling $6.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$6.0M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Arcellx, Inc. (ACLX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ACLXArcellx, Inc. | 24,000 | $2.8M |
| RNAAtrium Therapeutics Inc. | 126,645 | $1.7M |
| CNTACentessa Pharmaceuticals plc | 24,000 | $953K |
| APLSApellis Pharmaceuticals, Inc. | 6,000 | $241K |
| KZRKezar Life Sciences, Inc. | 24,000 | $178K |
| SCYXSCYNEXIS INC | 188,602 | $173K |
| BKHARBlack Hawk Acquisition Corp | 17,749 | $24K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.